Advertisement
Guest User

Untitled

a guest
Aug 31st, 2017
496
0
Never
Not a member of Pastebin yet? Sign Up, it unlocks many cool features!
text 3.45 KB | None | 0 0
  1. From "Potency" <ukkofyf@wilsaman.eu>
  2. To info@inventum.si
  3.  
  4. X-Spam-Checker-Version: SpamAssassin 3.4.0 (2014-02-07) on mycompany.com
  5. X-Spam-Flag: NO
  6. X-Spam-Level: **
  7. X-Spam-Status: Yes, score=3.0 required=4.0 tests=
  8. HTML_IMAGE_ONLY_04,HTML_MESSAGE,HTML_SHORT_LINK_IMG_1,MIME_HEADER_CTYPE_ONLY,
  9. MPART_ALT_DIFF,SPF_PASS,URIBL_BLOCKED autolearn=no autolearn_force=no
  10. version=3.4.0
  11. X-Spam-Report:
  12. * 0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was blocked.
  13. * See http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
  14. * for more information.
  15. * [URIs: pillsand.org]
  16. * -0.0 SPF_PASS SPF: sender matches SPF record
  17. * 0.7 MPART_ALT_DIFF BODY: HTML and text parts are different
  18. * 0.3 HTML_IMAGE_ONLY_04 BODY: HTML: images with 0-400 bytes of words
  19. * 0.0 HTML_MESSAGE BODY: HTML included in message
  20. * 1.0 BL_KEYWORD_TEEN FULL: Message contain words used in spam messages.
  21. * 0.0 MIME_HEADER_CTYPE_ONLY 'Content-Type' found without required MIME
  22. * headers
  23. * 1.0 HTML_SHORT_LINK_IMG_1 HTML is very short with a linked image
  24.  
  25. Received-SPF: Pass (sender SPF authorized) identity=mailfrom; client-ip=213.202.212.37; helo=mail.wilsaman.eu; envelope-from=ukkofyf@wilsaman.eu; receiver=info@mycompany.com
  26. Received: from mail.wilsaman.eu (mail.wilsaman.eu [213.202.212.37])
  27.  
  28. Message-ID: <ukkofyf06753438.74246775@mail.wilsaman.eu>
  29. Reply-To: "Potency" <ukkofyf@wilsaman.eu>
  30. From: "Potency" <ukkofyf@wilsaman.eu>
  31. To: <info@inventum.si>
  32. Subject: Drugs for potency
  33. Date: Thu, 31 Aug 2017 03:09:55 +0300
  34. Content-Type: multipart/related;
  35. type="multipart/alternative";
  36. boundary="----=_NextPart_000_0006_01D32206.177C8120"
  37. Precedence: bulk
  38. List-Id: b60124741v68320348
  39. X-Complaints-To: abuse@wilsaman.eu
  40. List-Unsubscribe: <http://wilsaman.eu/ru/unsubscribe/do?hash=6504803457156588>
  41. X-Spam-Prev-Subject: Drugs for potency
  42.  
  43. This is a multi-part message in MIME format.
  44.  
  45. ------=_NextPart_000_0006_01D32206.177C8120
  46. Content-Type: multipart/alternative;
  47. boundary="----=_NextPart_000_0007_01D32206.177C8120"
  48.  
  49. ------=_NextPart_000_0007_01D32206.177C8120
  50. Content-Type: text/plain;
  51. charset="windows-1251"
  52. Content-Transfer-Encoding: quoted-printable
  53.  
  54. =0D=0A=0D=0A=0D=0A=0D=0A=0D=0A
  55. ------=_NextPart_000_0007_01D32206.177C8120
  56. Content-Type: text/html;
  57. charset="windows-1251"
  58. Content-Transfer-Encoding: quoted-printable
  59.  
  60. <HTML><HEAD>=0D=0A<META http-equiv=3D"Content-Type" content=3D"te=
  61. xt/html; charset=3Dwindows-1251">=0D=0A</HEAD>=0D=0A<BODY bgColor=
  62. =3D#ffffff>=0D=0A<DIV align=3Dcenter><FONT size=3D2 face=3DArial>=
  63. <A href=3D"http://c.pillsand.org/"><IMG border=3D0 hspace=3D0 alt=
  64. =3D"" src=3D"cid:560b001d3220669edfc690a23f5bb8@ukkofyf" width=3D=
  65. 850 height=3D772></A></FONT></DIV></BODY></HTML>=0D=0A
  66.  
  67. ------=_NextPart_000_0007_01D32206.177C8120--
  68.  
  69. ------=_NextPart_000_0006_01D32206.177C8120
  70. Content-Type: image/jpeg;
  71. name="onkedayipi.jpeg"
  72. Content-Transfer-Encoding: base64
  73. Content-ID: <560b001d3220669edfc690a23f5bb8@ukkofyf>
  74.  
  75. /9j/4QAYRXhpZgAASUkqAAgAAAAAAAAAAAAAAP/sABFEdWNreQABAAQAAAA8AAD/4QMqaHR0cDov
  76. L25zLmFkb2JlLmNvbS94YXAvMS4wLwA8P3hwYWNrZXQgYmVnaW49Iu+7vyIgaWQ9Ilc1TTBNcENl
  77. aGlIenJlU3pOVGN6a2M5ZCI/PiA8eDp4bXBtZXRhIHhtbG5zOng9ImFkb2JlOm5zOm1ldGEvIiB4
  78. OnhtcHRrPSJBZG9iZSBYTVAgQ29yZSA1LjUtYzAxNCA3OS4xNTE0ODEsIDIwMTMvMDMvMTMtMTI6
  79. MDk6MTUgICAgICAgICI+IDxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5
  80. OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+IDxyZGY6RGVzY3JpcHRpb24gcmRmOmFib3V0PSIiIHht
  81. bG5zOnhtcE1NPSJodHRwOi8 ...
Advertisement
Add Comment
Please, Sign In to add comment
Advertisement